Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRV-015 in non-responsive celiac disease
NCT04424927Phase 2Completed
- Sponsor
- Sanofi
- Start
- Aug 2020
- Primary completion
- Jul 2024
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of ordesekimab in celiac disease, sponsored by Sanofi. Started Aug 2020; status: completed.
02
Drugs
ordesekimab
03
Conditions
celiac disease
Beyond the preview
Go deeper on NCT04424927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04424927.